日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Discovery of Potent and Selective MNK Kinase Inhibitors for the Treatment of Leukemia

发现用于治疗白血病的高效选择性MNK激酶抑制剂

Vagadia, Purav P; Izquierdo-Ferrer, Javier; Mazewski, Candice; Blyth, Gavin; Beauchamp, Elspeth M; Clutter, Matthew R; Stern, Charlotte L; Mishra, Rama K; Nahotko, Dominik; Small, Sara; Eckerdt, Frank; Platanias, Leonidas C; Schiltz, Gary E

Development of a SIN1 targeting inhibitor as a novel therapeutic approach for the treatment of malignancies

开发一种靶向SIN1的抑制剂作为治疗恶性肿瘤的新型治疗方法

Beauchamp, Elspeth M; Jain, Atul; Clutter, Matt; Nahotko, Dominik; Lopez Fajardo, Emely; Vagadia, Purav P; Dunne, Sara F; Mina, Alain; Fischietti, Mariafausta; Oku, Chidera V; Blyth, Gavin T; Mishra, Rama K; Karras, Elena; Radecki, Sara G; Lantz, Connor; Addepalli, Sidharth; Modi, Mirage; Zou, Lihua; Cho, Byoung-Kyu; Goo, Young Ah; Rossoff, Jenna; Fish, Eleanor N; Saleiro, Diana; Schiltz, Gary E; Platanias, Leonidas C

DART.2: bidirectional synaptic pharmacology with thousandfold cellular specificity.

DART.2:具有千倍细胞特异性的双向突触药理学

Shields Brenda C, Yan Haidun, Lim Shaun S X, Burwell Sasha C V, Cammarata Celine M, Fleming Elizabeth A, Yousefzadeh S Aryana, Goldenshtein Victoria Z, Kahuno Elizabeth W, Vagadia Purav P, Loughran Marie H, Zhiquan Lei, McDonnell Mark E, Scalabrino Miranda L, Thapa Mishek, Hawley Tammy M, Field Greg D, Hull Court, Schiltz Gary E, Glickfeld Lindsey L, Reitz Allen B, Tadross Michael R

Synthesis and Biological Evaluation of 3-Arylindazoles as Selective MEK4 Inhibitors

3-芳基吲唑类化合物作为选择性MEK4抑制剂的合成及生物学评价

Deibler, Kristine K; Schiltz, Gary E; Clutter, Matthew R; Mishra, Rama K; Vagadia, Purav P; O'Connor, Matthew; George, Mariam Donny; Gordon, Ryan; Fowler, Graham; Bergan, Raymond; Scheidt, Karl A